The Korea Pharmaceutical and Bio-Pharma Manufacturers Association on Friday urged its member companies to thoroughly prepare for a revised law that requires drug makers to label all ingredients from Dec. 3.
Under the new drug labeling law, manufacturers and importers of medicines are obliged to mark all the names of the ingredients, the quantity of the active ingredient and preservative on the drug’s container and the packing container.
The revised rule also requires a separate labeling of the active agent’s name and quantity and that of the additives, in the mentioned order. Preservatives, tar colors, and ingredients originating from an animal should be labeled before other additives. Other additives should be marked in Korean alphabetical order.
The mandatory labeling of all ingredients will be subject to medicines manufactured or imported after Dec. 3, 2017. Drugs made or imported before Dec. 3 will be subject to the new rule from a year later.
“Please be sure about inventory management and produce only an appropriate amount of products because those without a label of the full list of ingredients will be allowed until only Dec 2, 2018,” the association said in a statement to all member companies.
<© Korea Biomedical Review, All rights reserved.>